National Institute on Minority Health and Health Disparities; Notice of Closed Meeting, 8025 [2022-02919]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 29 / Friday, February 11, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Clinical Research
Education and Career Development (CRECD)
Program (R25-Independent Clinical Trial Not
Allowed).
Date: March 23, 2022.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Gateway
Plaza, 7201 Wisconsin Avenue, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Maryline Laude-Sharp,
Ph.D., Scientific Review Officer, Office of
Extramural Research Administration,
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, Gateway Building, 7201 Wisconsin
Avenue, Ste. 525, MSC. 9206, Bethesda, MD
20892, 301–451–9536, mlaudesharp@
mail.nih.gov.
Dated: February 7, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02919 Filed 2–10–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
Substance Abuse and Mental Health
Services Administration
Meeting of the Substance Abuse and
Mental Health Services Administration
National Advisory Council
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
Notice is hereby given for the
meeting on March 24, 2022 of the
SUMMARY:
VerDate Sep<11>2014
17:29 Feb 10, 2022
Jkt 256001
Substance Abuse and Mental Health
Services Administration National
Advisory Council (SAMHSA NAC). The
meeting is open to the public and can
only be accessed virtually. Agenda with
call-in information will be posted on the
SAMHSA website prior to the meeting
at: https://www.samhsa.gov/about-us/
advisory-councils/meetings. The
meeting will include, but not be limited
to, remarks from the Assistant Secretary
for Mental Health and Substance Use;
approval of prior meeting minutes;
updates on SAMHSA priorities; follow
up on topics related to the previous
SAMHSA NAC meeting; and council
discussions.
March 24, 2022, 1:00 p.m. to
approximately 5:00 p.m. (EDT)/Open.
ADDRESSES: The meeting will be held
virtually.
8025
samhsa.gov/MeetingList.aspx, or
communicate with SAMHSA’s
Committee Management Officer, Carlos
Castillo.
Meeting information and a roster of
Council members may be obtained
either by accessing the SAMHSA
Council’s website at https://
www.samhsa.gov/about-us/advisorycouncils/, or by contacting Carlos
Castillo.
Dated: February 5, 2022.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2022–02900 Filed 2–10–22; 8:45 am]
BILLING CODE 4162–20–P
DATES:
FOR FURTHER INFORMATION CONTACT:
Carlos Castillo, CAPT USPHS,
Committee Management Officer and
Designated Federal Official; SAMHSA
National Advisory Council, 5600
Fishers Lane, Rockville, Maryland
20857 (mail); telephone: (240) 276–
2787; email: carlos.castillo@
samhsa.hhs.gov
The
SAMHSA NAC was established to
advise the Secretary, Department of
Health and Human Services (HHS), and
the Assistant Secretary for Mental
Health and Substance Use, SAMHSA, to
improve the provision of treatments and
related services to individuals with
respect to substance use and to improve
prevention services, promote mental
health, and protect legal rights of
individuals with mental illness and
individuals with substance use
disorders or misuse.
Interested persons may present data,
information, or views orally or in
writing, on issues pending before the
Council. Written submissions must be
forwarded to the contact person no later
than seven days before the meeting. Oral
presentations from the public will be
scheduled for the public comment
section. Individuals interested in
making oral presentations must notify
the contact person by 4:00 p.m. (EDT),
March 17, 2022. Up to three minutes
will be allotted for each presentation,
and as time permits, as these are
presented in the order received. Public
comments received will become part of
the meeting records.
To obtain the call-in number, access
code, and/or web access link; submit
written or brief oral comments; or
request special accommodations for
persons with disabilities, please register
on-line at: https://snacregister.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[CBP Dec. 22–03]
Termination of the In-Bond Export
Consolidator Program and Associated
Bond
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This document announces the
termination of the In-Bond Export
Consolidator program (IBEC program)
and the associated bond, known as the
In-Bond Export Consolidation bond
(IBEC bond), implemented at Customs
District 52 (Miami). Consequently, IBEC
program participants who intend to
continue their operations must
transition their facility status to either a
customs bonded warehouse, container
freight station, foreign trade zone, or a
facility operated as a non-vessel
operating common carrier, depending
on their business needs, and also obtain
the appropriate bond(s). U.S. Customs
and Border Protection (CBP) is
providing a transition period of one year
from the date of this notice for IBEC
program participants (including both
IBEC program facilities and the
operators who manage the facilities) to
transition the status of their facilities, as
set forth in this notice.
DATES: IBEC program participants
(including both IBEC program facilities
and the operators who manage the
facilities) who intend to continue inbond export consolidation operations
have until February 11, 2023 to
transition to one of the alternate facility
types listed in this notice and obtain the
appropriate bond(s). As of February 11,
2022, CBP will no longer accept
applications for new IBEC bonds
SUMMARY:
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 87, Number 29 (Friday, February 11, 2022)]
[Notices]
[Page 8025]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02919]
[[Page 8025]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Minority Health and
Health Disparities Special Emphasis Panel; Clinical Research
Education and Career Development (CRECD) Program (R25-Independent
Clinical Trial Not Allowed).
Date: March 23, 2022.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Gateway Plaza, 7201 Wisconsin
Avenue, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maryline Laude-Sharp, Ph.D., Scientific Review
Officer, Office of Extramural Research Administration, National
Institute on Minority Health and Health Disparities, National
Institutes of Health, Gateway Building, 7201 Wisconsin Avenue, Ste.
525, MSC. 9206, Bethesda, MD 20892, 301-451-9536,
[email protected].
Dated: February 7, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02919 Filed 2-10-22; 8:45 am]
BILLING CODE 4140-01-P
